Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.
Not Applicable
- Conditions
- Ischemic Heart Disease,Diabetes Mellitus
- Registration Number
- JPRN-UMIN000007255
- Lead Sponsor
- Center for Cardiovascular Interventions,Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with severe coronary stenosis who are eligible for IVUS. 2)Acute myocardial infarction 3)Patients who have unprotected LMT lesion. 4)Severe renal disease or/and serum creatinine level>2.0mg/dl 5)Left ventricular ejection fraction=<40% 6)Type1 diabetes mellitus 7)Allergy for antiplatelet,anticoagulant drug,dipeptidyl-peptidase4 inhibitor and sulfonylureas 8)Severe liver dysfunction 9)Pregnancy 10)Other patients judged as being inappropriate for the subjects of the study by investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method